Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Covid-19 Diagnostics Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Covid-19 Diagnostics Market Business Segmentation
2.5 Covid-19 Diagnostics Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Covid-19 Diagnostics Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Covid-19 Diagnostics Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Covid-19 Diagnostics Market has been analysed to include the below segmentation:
BY TEST TYPE
• PCR
• Antigen Tests
• Antibody Tests
BY PRODUCT TYPE
• Consumables
• Analyzers
BY END-USER
• Diagnostic Laboratories
• Hospitals
• Ambulatory Care Settings
• Research Institutes
BY TECHNOLOGY
• Molecular Assay
• Immuno assay
Chapter 5A. Regional Segmentation
The Covid-19 Diagnostics Market has been analysed by studying the following regions:
North America
• BY TEST TYPE
• BY PRODUCT TYPE
• BY END-USER
• BY TECHNOLOGY
Europe
• BY TEST TYPE
• BY PRODUCT TYPE
• BY END-USER
• BY TECHNOLOGY
APAC
• BY TEST TYPE
• BY PRODUCT TYPE
• BY END-USER
• BY TECHNOLOGY
LatAm
• BY TEST TYPE
• BY PRODUCT TYPE
• BY END-USER
• BY TECHNOLOGY
MEA
• BY TEST TYPE
• BY PRODUCT TYPE
• BY END-USER
• BY TECHNOLOGY
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Covid-19 Diagnostics Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Covid-19 Diagnostics Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Covid-19 Diagnostics Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• ABBOTT
• SIEMENS HEALTHINEERS
• F HOFFMANN-LA ROCHE
• THERMO FISHER SCIENTIFIC
• DANAHER
• BD
• ABINGDON HEALTH
• ACCESS BIO
• ASSURE TECH (HANGZHOU)
• AUTOBIO
• ADVAITE
• BABSON DIAGNOSTICS
• BEIJING WANTAI BIOLOGICAL
• BIOMERICA
• BIOM•RIEUX
• BIOPANDA REAGENTS
• BIOCERNA
• BIOCAN DIAGNOSTICS
• BIOMEDOMICS
• CLINICAL REFERENCE LABORATORY
• CELLEX
• THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
• CTK BIOTECH
• DIASORIN
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us